SCHEMBL10551

SCHEMBL10551

CC(C)CC(C)(C)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12314824 0.92 CYP2D6 (0.45)
SCHEMBL12314822 0.88 CYP2D6 (0.47)
SCHEMBL26234244 0.80 CYP2D6 (0.39)
SCHEMBL13249198 0.79 TSHR (0.31)
SCHEMBL10060803 0.79
SCHEMBL4167824 0.79 CYP2D6 (0.50)
SCHEMBL20147019 0.77
SCHEMBL24723754 0.75 CYP2D6 (0.37)
SCHEMBL20957529 0.75
SCHEMBL4468978 0.75 CYP2D6 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820846-B1 COMPOSITION FOR INHIBITING MONOMER POLYMERIZATION COMPRISING A NITROXIDE INHIBITOR, A QUINONE METHIDE RETARDER AND AN AMINE STABILIZER ECOLAB USA INC (US) 2024-01-03 EP disclosed
WO-2023212057-A1 COMPOSITIONS OF KINETIC NANOPARTICLES CONTAINING NUCLEIC ACIDS, POLYCATIONS AND LIPIDS THE JOHNS HOPKINS UNIVERSITY (US) 2023-11-02 WO disclosed
US-20230338415-A1 SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE GLYSCEND, INC. 2023-10-26 US disclosed
WO-2023154818-A1 MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS MODERNATX, INC. (US) 2023-08-17 WO disclosed
US-11697804-B2 Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy THE JOHNS HOPKINS UNIVERSITY (US) 2023-07-11 US disclosed
WO-2023093845-A1 CHIMERIC COMPOUND FOR TARGETED DEGRADATION OF ANDROGEN RECEPTOR PROTEIN, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2023-06-01 WO disclosed
WO-2023077150-A1 POLYMERS AND NANOPARTICLES FOR INTRAMUSCULAR NUCLEIC ACID DELIVERY THE JOHNS HOPKINS UNIVERSITY (US) 2023-05-04 WO disclosed
WO-2023069549-A1 METHODS AND COMPOSITIONS COMPRISING PEPTIDOMIMITICS FOR TREATING, PREVENTING, INHIBITING, AMELIORATING OR DELAYING THE ONSET OF OPHTHALMIC CONDITIONS STEALTH BIOTHERAPEUTICS INC. (US) 2023-04-27 WO disclosed
US-11576928-B2 Substituted phenyl boronic acid containing polymers and methods of use GLYSCEND, INC. (US) 2023-02-14 US disclosed
US-20220396651-A1 BENZOXABOROLE POLYMERS AND METHODS OF USE GLYSCEND, INC. 2022-12-15 US disclosed
EP-0285383-A2 Treatment of prostatic carcinoma with 17beta-n-monosubstituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones MERCK & CO. INC. (US) 1988-10-05 EP disclosed
EP-0285382-A2 Treatment of androgenic alopecia with 17beta-n-monosubstituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones MERCK & CO. INC. (US) 1988-10-05 EP disclosed
US-4760071-A Enzyme inhibitor MERCK & CO., INC. (US) 1988-07-26 US disclosed
US-4558101-A FROM HYDROCARBON POLYMER CONTAINING OLEFINIC GROUPS WITH HYDROGEN CARBON MONOXIDE AND AMINE USING GROUP 8 METAL CATALYST W. R. GRACE & CO. (US) 1985-12-10 US disclosed
EP-0155096-A2 17 Beta-Substituted-4-aza-5-alpha-androstenones and their use as 5-alpha-reductase inhibitors MERCK & CO. INC. (US) 1985-09-18 EP disclosed
US-4526936-A Reacting polymeric hydrocarbon, primary or secondary amine, carbon monoxide, hydrogen, in the presence of group VIII metal catalyst W. R. GRACE & CO. (US) 1985-07-02 US disclosed
US-4312965-A Process for forming amine/amide containing polymers W. R. GRACE & CO. (US) 1982-01-26 US disclosed
US-4113764-A Manufacture of N-substituted glycinonitriles BASF AKTIENGESELLSCHAFT (DE) 1978-09-12 US disclosed
US-4083849-A Process for preparation of 5-cyanopyrid-6-ones BASF AKTIENGESELLSCHAFT (DT) 1978-04-11 US disclosed
US-4022815-A Manufacture of substituted glycinonitriles BASF AKTIENGESELLSCHAFT (DT) 1977-05-10 US disclosed